
Newly opened research room at the proton beam centre at the Christie Hospital Manchester (photo courtesy of Christie Hospital)
Conventional radiotherapy for ophthalmology involves use of high energy X-ray photon beams or so called plaque radiotherapy using implanted radioactive sources.
Such conventional radiotherapy, however, is associated with unavoidable collateral damage to adjoining tissues and where in particular damage to optic nerve and fovea region can be significant.
Proton beam radiotherapy has become available as a specialist technique for the treatment of ocular cancers and where the principal advantage of such a mode of treatment is that it causes less damage to neighbouring tissues than conventional radiotherapy techniques and, consequently, has greater potential to preserve visual acuity.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here